- Home
- PLSE vs STAA Comparison
PLSE vs STAA Comparison
Compare PLSE & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSE | STAA |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 1.1B |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PLSE | STAA |
|---|---|---|
| Price | $51.88 | $19.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $22.00 | ★ $22.81 |
| AVG Volume (30 Days) | 593.4K | ★ 780.8K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | $840.00 | $30.82 |
| Revenue Next Year | $287.54 | $8.41 |
| P/E Ratio | ★ N/A | $76.15 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.56 | $15.59 |
| 52 Week High | $58.90 | $35.87 |
Technical Indicators
Market Signals| Indicator | PLSE | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 56.93 | 31.21 |
| Support Level | $49.01 | $19.82 |
| Resistance Level | $58.90 | $20.49 |
| Average True Range (ATR) | 4.41 | 0.97 |
| MACD | -0.62 | -0.25 |
| Stochastic Oscillator | 45.36 | 6.26 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.